Skip to main content

Table 2 Changes in clinical outcome in baseline, three months and 12 months

From: Prevention of Type 2 Diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project

  n Baseline mean (SD) Change from baseline to 3 months* mean (95% CI) Change from baseline to 12 months mean (95% CI) Change at 12 months %
Weight (kg) 237 91.7 (17.7) -2.38 (-2.79,-1.98) -2.52 (-3.19,-1.85) -2.7
Body-mass index (kg/m2) 237 33.5 (5.9) -0.88 (-1.03,-0.74) -0.93 (-1.17,-0.69) -2.8
Waist circumference (cm) 236 104.9 (13.0) -3.16 (-3.72,-2.60) -4.17 (-4.87,-3.48) -4.0
Hip circumference (cm) 236 115.7 (12.5) -1.56 (-2.04,-1.07) -2.65 (-3.26,-2.05) -2.3
Plasma glucose (mmol/l)      
   Fasting 237 5.53 (0.54) 0.00 (-0.07,0.08) -0.14 (-0.20,-0.07) -2.5
   2 Hr oral glucose challenge 232 6.70 (1.69) - -0.58 (-0.79,-0.36) -8.6
Serum lipids (mmol/l)      
   Total cholesterol 237 5.67 (1.15) -0.21 (-0.32,-0.09) -0.29 (-0.40,-0.18) -5.1
   Low-density lipoprotein cholesterol 229 3.44 (0.99) -0.16 (-0.25,-0.07) -0.25 (-0.34,-0.16) -7.3
   High-density lipoprotein cholesterol 237 1.34 (0.37) 0.01 (-0.02,0.03) 0.06 (0.03,0.09) +4.4
   Triglycerides 237 1.90 (1.00) -0.10 (-0.20,0.01) -0.15 (-0.24,-0.05) -7.6
Blood pressure (mmHg)
   Systolic 236 132.1 (17.1) -1.67 (-3.3,-0.04) -1.01 (-2.60,0.58) -0.8
   Diastolic 236 81.0 (9.9) -0.99 (-2.18,0.20) -2.14 (-3.33,-0.94) -2.6
  1. * At the 3 month clinical test, n value varied between 216 and 221.